It all depends on how they stratify the data derived from the patients in the study. I think they have made this clear enough in recent ASX releases, which are worth reading and digesting. I hold a small parcel; I think that they are worth holding for a while longer while we wait to see which way the wind is blowing.
safe speccie, page-3
Add BXN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $20.46M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $1.861K | 186.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1824559 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 363333 | 3 |
View Market Depth
| Last trade - 10.18am 15/10/2024 (20 minute delay) ? |
| BXN (ASX) Chart |